Biosimilar Antibodies

Biosimilar Antibodies are antibodies sharing identical active biological components with the original therapeutic antibodies, serving as positive controls for drug efficacy evaluation in scientific research and supporting functional validation of target proteins.
Search results for
Showing 1 – 10 of4,549products
Epcoritamab Brand Logo
ID: BAB738951325

Epcoritamab, Abbexa, abx831545

Epcoritamab is a monoclonal antibody biosimilar expressed in CHO cells, targeting CD3E/MS4A1/CD20, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Epcoritamab (DuoBody®-CD3xCD20) is a proprietary bispecific antibody created using Genmab’s DuoBody technology. It targets CD20 on the B-cells, a clinically well-validated target that is expressed in a wide variety of B-cell malignancies. Epcoritamab is currently under investigation in a Phase I/II study for multiple hematological B cell malignancies.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Fazpilodemab Brand Logo
ID: BAB051457572

Fazpilodemab, Abbexa, abx831815

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Fazpilodemab is a Chimeric Humanized Monoclonal antibody targeting FLT2, expressed in Mammalian cells.

Host

CHO cells

Reactivity

Human

Applications

SDS-PAGE

Conjugation

Enibarcimab Brand Logo
ID: BAB676470066

Enibarcimab, Abbexa, abx831631

Enibarcimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting ADM, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Retifanlimab Brand Logo
ID: BAB613988807

Retifanlimab, Abbexa, abx831561

Retifanlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Retifanlimab (INCMGA-0012) is an anti-PD-1 monoclonal antibody. INCMGA0012 is currently in the clinical proof-of-concept (PoC) stage. At the same time, Incyte is exploring the efficacy of INCMGA0012 monotherapy in high satellite unstable endometrial cancer and Merkel cell carcinoma.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Dostarlimab Brand Logo
ID: BAB926495054

Dostarlimab, Abbexa, abx831486

Dostarlimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting PDCD1/PD1/CD279, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Dostarlimab (TSR-042) is a humanized anti-PD-1 monoclonal antibody jointly developed by TESARO and AnaptysBio. It binds to the PD-1 receptor with high affinity, thereby blocking its binding to PD-L1 and PD-L2 ligands.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Tarcocimab Brand Logo
ID: BAB551507548

Tarcocimab, Abbexa, abx831740

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Tarcocimab is a Humanized Monoclonal antibody, expressed in Mammalian cells.

Host

CHO cells

Reactivity

Human

Applications

Conjugation

Aducanumab Brand Logo
ID: BAB176520042

Aducanumab, Abbexa, abx831294

Aducanumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting APP Abeta, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Aducanumab has been used in trials studying the treatment of Alzheimer's Disease.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Volagidemab Brand Logo
ID: BAB489026289

Volagidemab, Abbexa, abx831515

Volagidemab is a monoclonal antibody biosimilar expressed in CHO cells, targeting GCGR, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Pascolizumab Brand Logo
ID: BAB364063771

Pascolizumab, Abbexa, abx831029

Pascolizumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL4, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Pascolizumab (SB 240683) is a humanized anti-interleukin-4 antibody with therapeutic potential in asthma. Pascolizumab is a humanized anti-IL-4 monoclonal antibody that can inhibit upstream and downstream events associated with asthma, including (T(H)2) cell activation and immunoglobulin E production.

Host

Human

Reactivity

Human

Applications

ELISA, WB

Conjugation

Unconjugated

Reozalimab Brand Logo
ID: BAB676570018

Reozalimab, Abbexa, abx831793

This product is for research use only (RUO) by laboratories. It is not suitable for use in humans or as a medicine. Reozalimab is a Human Monoclonal antibody targeting B7-H1, expressed in Mammalian cells.

Host

CHO cells

Reactivity

Human

Applications

Conjugation

Request a product

Please provide the required information below so that we can quickly source your products.